RPS6KA3 and mantle cell lymphoma: In this study, we investigated the activation status of RSK2Ser227 in MCL and the functional roles of RSK2, and especially RSK2Ser227, in MCL‐derived cell lines to examine the value of RSK2 as a therapeutic target in MCL.